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Abstract
Background: Adherence to antiretroviral medication regimens is essential to good clinical outcomes for HIV-
infected patients. Little is known about the costs of case management (CM) designed to improve adherence for
patients identified as being at risk for poor adherence in resource-constrained settings. This study analyzed the
costs, outputs, unit costs and correlates of unit cost variation for CM services in 14 ART sites in Ethiopia from
October 2008 through September 2009.
Methods: This study applied standard micro-costing methods to identify the incremental costs of the CM
program. We divided total CM-attributable costs by three output measures (patient-quarters of CM services
delivered, number of patients served and successful patient exits) to derive three separate indices of unit costs. The
relationships between unit costs and two operational factors (scale and service-volume to staff ratios) were
quantified through bivariate analyses.
Results: The CM program delivered 4,598 patient-quarters of services, serving 5,056 patients and 1,995 successful
exits at a cost of $167,457 over 12 months, or $36 per patient-quarter, $33 per patient served and $84 per
successful exit from the CM program. Among the 14 sites, mean costs were $11,961 (sd, $3,965) for the 12-month
study period, and $51 (sd, $36) per patient-quarter; $48 (sd, $32) per patient served; and $183 (sd, $157) per
successful exit. Unit costs varied inversely with scale (r, -0.70 for cost per patient-quarter versus patient-quarters of
service) and with the service-volume to staff ratio (r, -0.68 for cost per patient-quarter versus staff per patient-
quarter).
Conclusions: For those receiving CM, the program adds 0.52% to the lifetime cost of ART. These data reflect wide
variation in unit costs among the study sites and suggest that high patient volume may be a major determinant of
CM program efficiency. The observed variations in unit costs also indicate that there may be opportunities to
identify staffing patterns that increase overall program efficiency.
Background
Over 1.1 million HIV-infected individuals reside in Ethio-
pia [1]. Adult HIV prevalence was estimated at 1.8% to
2.2% in 2009, low by the standards of sub-Saharan Africa
[2]. Provision of free antiretroviral therapy (ART) started
in October 2005, leveraging support from both the Glo-
bal Fund to Fight AIDS, Tuberculosis and Malaria
(GFATM) and the United States President’sE m e r g e n c y
Plan for AIDS Relief (PEPFAR) [3]. Ethiopia is among
PEPFAR’s 15 most highly-funded “focus” countries. PEP-
FAR funding for ART scale-up rose rapidly over a 5 year
period, from over $49 million in fiscal year (FY) 2004 to
$354.5 million in FY 2008 [4]. Spending declined slightly
to a planned $346 million in FY 2009. As a result of this
investment, 163,100 patients received ART in 2009,
country-wide. In the context of the current flat-lining of
PEPFAR HIV funding [5], combined with substantial
projected increases in the number of HIV-infected people
who will be clinically eligible for treatment, the need to
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various ways of structuring HIV treatment programs and
adjunct services has never been greater. Case manage-
ment (CM) to improve adherence, slow disease progres-
sion, lower costs and reduce the risk of the spread of
treatment-resistant HIV virus to the community has
received little attention.
The relationship between adherence to ART and favor-
able clinical outcomes is well established [6,7]. There is
now also substantial evidence that good adherence may be
associated with lower spending, likely due to improve-
ments in the health status of adherent patients. Although
the independent causal role of better adherence cannot be
inferred from this study, a 2010 analysis of a South African
managed care setting found that treatment and care costs
were highest in the lowest quartile of adherence. Monthly
costs in this lowest quartile were higher than quartiles 2,
3, and 4 by US$30, $59 and $85, respectively. The net sav-
ings reflected reductions in spending on opportunistic
infections that exceeded the higher spending on ART [8].
The full social and economic benefits of greater adherence
are underestimated by these results since they omit poten-
tially improved labor productivity [9]. Other benefits
include the subjective value of improved health to the
patients and their families, and a lower risk to the commu-
nity from the spread of resistant strains of HIV.
A non-randomized study in the United States found that
individual case management for homeless HIV-infected
clients improved adherence and CD4 counts [10]. We are
unaware of similar studies in sub-Saharan Africa or other
developing countries, though a simulation study set in
Cote d’Ivoire found that adherence interventions (not
including CM) are likely to be both effective and cost-
effective in preventing loss to follow-up in resource-con-
strained settings [11]. The question of whether the cost of
CM programs to improve adherence is justified by the
benefits remains unanswered. The current study aims to
provide part of the answer to that question by (1) estimat-
ing the unit costs of case management services for ART
patients in three provinces in Ethiopia, (2) documenting
the variation in those costs, and, (3) exploring the oppor-
tunities for greater efficiency in the provision of CM
services.
Methods
Overview
The International Training and Education Center for
Health (I-TECH) is a collaboration between the Univer-
sity of Washington and the University of California, San
Francisco. It receives its principal funding from PEPFAR
via the Health Resources and Services Administration
and operates in 15 countries seeking to strengthen health
delivery systems through training, evaluation and support
for clinical services. In this study, we computed the
monetized value of the resources consumed by CM activ-
ities carried out by I-TECH in cooperation with the
Federal Ministry of Health of Ethiopia. We applied stan-
dard micro-costing methods in which each type of
resource is quantified and assigned a unit cost [12]. We
divided total CM-attributable costs by two output mea-
sures in order to derive two separate indices of unit
costs, cost per patient-quarter of CM provided, and cost
per successful exit from the program. The largest share
of costs, those devoted to supporting the full-time staff
providing direct CM services, was represented as an
incremental cost of the CM program, that is the costs of
CM activities entailed beyond ongoing ART operating
costs. Overhead and administrative costs incurred at I-
TECH headquarters in Addis Ababa were assigned to the
CM program on an incremental basis where possible,
and otherwise, according to the proportion that CM
direct service staff constituted of total I-TECH direct ser-
vice staff during the study period.
Historical salary and expenditure records were queried
from QuickBooks, an electronic accounting system used
to manage finances for the I-TECH program in Ethiopia.
These expenditure data were verified with interviews of
project managers, service delivery staff, and accounting
staff. Costs were assessed from the perspective of the CM
services provider. Time, cos t so rc o s t - s a v i n g sf r o m
improved adherence, and other possible costs to patients
were not assessed. All costs were converted from Ethio-
pian Birr to US dollars, at the exchange rate for March 31,
2009 (11.2 Birr/US $; http://www.oanda.com/currency/his-
torical-rates/), the mid-point of the data period. Results
are presented in 2009 dollars.
Setting, intervention and study period
I-TECH provides support, including CM, to 46 health care
sites in the three northern regions of Amhara, Afar, and
Tigray, which account for nearly 50% of the national HIV
burden. More than 241 I-TECH staff members facilitate
government-sanctioned healthcare activities including
training and capacity building, other health systems
strengthening, and monitoring and evaluation. In 2006, at
the request of the Federal HIV/AIDS Prevention and Con-
trol Office/Ministry of Health of Ethiopia, I-TECH Ethio-
pia and Visions for Development, Inc (VDF) developed a
national model for case management for patients at risk of
poor adherence. The program was validated and operatio-
nalized, first in six pilot hospitals and then successively
expanded to a total of 46 sites. Case managers are trained
using a national curriculum, and are high school graduates
with modest experience in community health. We selected
October 2008 - September 2009 as the study period since
12 months account for any seasonal caseload fluctuations,
and administrative and compensation practices at all CM
sites were the same during this period. Fourteen sites were
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in operation for at least 12 months; these included nearly
a third of the sites with case management programs.
Patients at the ART clinic are referred by their ART
clinicians to CM services based on presenting adherence
risk factors, such as alcohol or khat (stimulant) depen-
dency, lack of disclosure of HIV status to family mem-
bers, lack of basic needs such as food, shelter and
transportation, and disease severity or co-morbidity. The
case management services consist of adherence counsel-
ing and support; health education; peer support; and
referral of clients to community based organizations
equipped to address specific barriers to adherence such
as malnutrition, substance abuse or material needs for
clothing, rent, and food.
Client characteristics and continuity of care at baseline
A convenience sample survey of ART patients was con-
ducted between May and June of 2007 (n = 60) in the six
original sites chosen to pilot the case management pro-
gram. It found that 85% were aged 20-45 and 15% were
46 - 65; females were 58% of the total; 75% of clients
were unemployed; 37% were illiterate; and 33% had not
disclosed their HIV status to their families [13]. A 2002
evaluation of the I-TECH-supported ART facilities in
Amhara and Tigray found that 10 - 25% of ART patients
did not return for appointments within 30 days of the
scheduled date. This finding was part of the impetus to
initiate a CM program [14].
Data collection
A member of the UCSF research team visited the I-TECH
offices in Addis Ababa to assess CM expenditures during
a 10-day site visit in June 2010. The team member con-
sulted with I-TECH Ethiopia staff, including human
resources, treatment program staff, financial administra-
tion staff, and the case management coordinator. He also
visited two case management sites (Felege Hiwot Hospital
and Gondar University Hospital) to gain additional under-
standing of the operational context and activities of the
case management program. Refinement of the cost data
collected during the visit was completed over three subse-
quent months via e-mail and conference call exchanges.
Direct services provision
Service delivery personnel costs were collected through
the examination of relevant reports generated by I-
TECH’sQ u i c k B o o k s
® database. The team reviewed
records of the I-TECH staff complement for the study per-
iod and identified staff associated with the case manage-
ment program at the study sites. These included Case
Managers, Adherence Supporters, and the Case Manage-
ment Supervisors. We consulted with financial staff to
determine relevant salaries, benefits and health insurance
costs. Case Manager Supervisors divide their time between
two to four sites, and we allocated their compensation
expenses across these sites accordingly.
Training
Training costs were included in the QuickBooks
® data-
base, and these costs were verified through the review of
training schedules before and during the study period.
Costs included facility rental, refreshments, materials, and
associated travel and per diem costs. In the absence of spe-
cific relevant data, we assumed that training activities and
associated costs would be renewed every three years.
Capital purchases
The site visit included meetings with the procurement and
operations staff to review the purchase and use of capital
goods such as vehicles and office equipment, for the case
management program. All capital procurements were
amortized over five years of estimated useful life. Donated
used computer equipment was assessed at 50% of the mar-
ket cost of equivalent new equipment.
Overhead
Overhead cost data collection was conducted in collabora-
tion with the I-TECH financial management team. The
QuickBooks
® system does not allocate costs on a by-pro-
gram basis, so we manually assigned relevant portions of
line items to case management from the expenditure
reports. Monthly expenditure data were then generated
for the study period across all available overhead cost cate-
gories, including management personnel costs, curriculum
development, office rental, and travel costs. Functions that
supported I-TECH activities in ways that were harder to
assign to specific programs, such as telecommunications,
information technology, and utilities, were allocated to
CM in proportion to the CM program’s share of I-TECH
direct services staff. Headquarter office rental costs were
assigned to the CM program based on the proportion of
CM office space to all headquarter office space.
Outputs
Services volume expressed as “patient-quarters of CM
delivered” was tabulated from standardized quarterly
reporting forms compiled by Case Manager Supervisors.
The number of patient-quarters was estimated using the
number of new entries into the CM program the numbers
restarting CM after discharge and continuing with the
program, and the number exiting each quarter. We
assume that entry or exit events were distributed randomly
across each respective quarter, and thus occurred on aver-
age six weeks (half-way) through the quarter. Thus, the
number of patient-quarters in any quarter is: 50% x (New
entries + Re-starting clients) + Continuing - 50% x Exits for
all reasons.
The number of patients served cannot be directly
obtained from the quarterly report forms. However, a
review of log data in Felege Hiwot Hospital (West Amhara
Region), Adigrat Hospital (Tigray Region) and Awash
Health Center (Afar Region) found that the average
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respectively. These averages were applied to the other data
on patient-quarters of CM sites in the respective regions
to derive an estimate of the number of patients served at
each site.
The third output measure, “Successful exits”,w a s
defined as patients whose barrier to adherence has, in the
judgment of the case manager, been resolved, or who have
been successfully referred to a community-based organiza-
tion that affirms that the patient is receiving needed ser-
vices. The total number of successful exits was obtained
from the quarterly report form.
Results
Outputs and costs
During the 12-month study period, the I-TECH Ethiopia
CM program delivered 4,598 patient-quarters of services
in the 14 study sites, or 328 on average [Median per site,
251; sd, 274]. 5,056 patients were served [Median per site:
271; sd, 292]. A total of 1,995 clients successfully exited
the program, or 143 per site [Median: 83; sd, 232]. The
total value of resources consumed by the CM program
across the 14 sites, including the amortized costs of capital
items and training, and allocated overhead expenses, was
$167,457, or an average of $11,961 per site [Median:
$11,268; sd, $3,965]. See Table 1.
The average cost per patient-quarter of CM services was
$36 [Median: $45; sd, $38]. The average cost per patient
served was $33 [Median: $41; sd, $32] and the average
cost per client who successfully exited the CM program
was $84 [Median: $162; sd, $157]. The rural hospital at
Debire Tabor had the highest unit costs ($114 per patient-
quarter and $674 per successful exit), the result of roughly
average total cost distributed over the smallest CM case-
load. Felege Hiwot referral hospital had the lowest unit
costs ($16 per patient-quarter and $20 per successful exit),
accounting for 24.9% of CM patient-quarters delivered
and 46.7% of all successful exits.
Compensation for personnel delivering CM services and
their immediate supervisors accounted for 77.5% of spend-
ing; 16.6% supported overhead costs at I-TECH headquar-
ters in Addis Ababa; 4.7% was due to the amortized cost
of training; 0.7% was for the amortized cost of capital
goods; and 0.5% supported overhead at the regional I-
TECH offices (Figure 1). Overhead costs at headquarters
in Addis Ababa consisted of contractual services for curri-
culum and guidelines development (33.9%); administration
(27.0%), telecommunications and I.T. (17.2%); rent
(10.6%); utilities (2.0%) and miscellaneous expenses such
as printing and travel (9.2%). See Figure 1.
Variations by scale
In bivariate analyses, scale was inversely associated with
unit cost for both patient-quarters and successful exits,
with R
2 of 0.484 and 0.357, respectively. (See Figures 2
and 3).
The cost per successfully exited client and the cost per
patient quarter of CM have a correlation of 0.725 (R
2,
0.53). The correlation between the number of successful
exits and the number of patient-quarters of CM delivered
is 0.86 (R
2, 0.74).
We also compared unit cost with the ratio of the volume
of services at each site to the number of full-time equiva-
lent staff delivering direct services. We found that the cor-
relation between the two was negative; that is, the sites
with higher volumes of services per staff member tended
to have lower unit costs (r = -0.49 and -0.68 for cost per
successful exits and cost per patient-quarters of CM deliv-
ered, respectively).
Potential for greater efficiency
As shown in Table 1 and in Figures 2 and 3, there is sub-
stantial variation in unit costs among the 14 study sites.
This may suggest the potential for greater efficiency in
the more expensive sites. If sites with unit costs at the
75
th percentile or higher had the average unit costs of
t h o s eu n d e rt h e7 5
th percentile, the savings could fund
additional services that would increase the number of
patient-quarters of CM by 23.7%, and the number of suc-
cessful exits by 22.8%. If it were possible for the program
as a whole to emulate the performance of Felege Hiwot, a
2.2-fold increase in patient-quarters of CM services and a
4.2-fold increase in successful exits could be sustained by
the $167,457 spent during the study period.
Discussion
In this study examining the costs and outputs of 14 I-
TECH sponsored HIV treatment case management sites
in Ethiopia, we found that the I-TECH Ethiopia program
delivered 4,589 patient-quarters of services, served 5,056
patients and 1,995 successful exits at a cost of $167,457
over 12 months, or $36 per patient-quarter, $33 per
patient served, and $84 per successful exit. Unit costs var-
ied inversely with scale across sites. These results suggest
that higher services volume may be an important determi-
nant of higher efficiency for CM. However, there are lim-
itations to what program managers can do to increase
ART and CM uptake, as this depends importantly on HIV
prevalence, population density, and access issues which
may be outside of their control. However, we also found
strong negative correlation between client-staff ratios and
unit costs. This indicates that observed economies of scale
are not only due to the spreading of fixed costs over larger
services volumes, but that higher service volumes are asso-
ciated with higher staff productivity. How the relationship
between volume and productivity is mediated is not clear
from our data. Personnel costs are conventionally classi-
fied as variable costs. However, a case manager may in the
short run be a fixed cost in that “one” is the indivisible
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CM program outputs Cost Unit costs
Province ART site Patient-
Quarters of
CM
Patients
served
1
Successful
exits
Expenditures for Case
Management
Cost per Patient-
quarter of CM
Cost per
person served
Cost per successful
completion
Debre
Markos
529 570 89 $10,419 $20 $18 $117
Woldia 234 253 76 $12,465 $53 $49 $164
Gondar 269 290 100 $16,007 $60 $55 $160
Amhara Debire
Tabor
85 91 18 $12,136 $144 $133 $674
Debre
Berhan
168 181 128 $7,577 $45 $42 $59
Dessie 435 469 159 $19,330 $44 $41 $122
Felege
Hiwot
1,146 1,237 933 $18,775 $16 $15 $20
Axum 270 323 45 $8,519 $32 $26 $189
Humera 153 183 129 $14,603 $95 $80 $113
Tigray Alamata 199 238 142 $9,335 $10 $39 $66
Mekelle 195 232 42 $11,667 $60 $50 $278
Adigrat 105 125 49 $9,468 $90 $75 $193
Awash 525 558 56 $10,869 $21 $19 $194
Afar Dubti 287 305 29 $6,288 $22 $21 $217
Total 4,598 5,056 1,995 $167,457 N/a N/a N/a
Mean per site: 328 361 143 $11,961 $51 $48 $183
Standard
Dev.
274 292 232 $3,965 $38 $32 $157
Median: 251 271 83 $11,268 $45 $41 $162
Mean per-patient
cost
$36 $33 $84
Data from October 2008 - September 2009.
1. Patients served derived from caseload log counts from hospitals in Felege Hiwot, Adigrat and Awash. Patients
served were estimated for the other facilities in each province based on the ratio of patients served to patient-quarters provided in the hospital in the province
for which log data were tabulated.
Figure 1 Program costs by major component in 14 ART-provision sites in Amhara, Tigray and Afar provinces. Data from October 2008
through September 2009.
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It is possible that efficiency would be increased, even
absent greater volume if, at sites with higher costs and
lower volumes, case managers were able to divide their
time between CM and other HIV-related services. Alterna-
tively, if there are sites with under-utilized case manger
staff time, it might be possible to intensify CM services to
clients and potentially generate a larger number of suc-
cessful exits with existing staff levels. Some degree of flex-
ibility and adaptability of the CM model to local
conditions may be essential for efficient service delivery.
Indeed, at some sites case managers have started to
assume limited responsibility for other services to HIV
inpatients.
A significant limitation of this analysis is that it was
not always possible to quantify the portion of adminis-
trative staff time and other overhead resources that
would have been needed in the absence of the CM pro-
gram, i.e., the incremental opportunity cost of the over-
head inputs. We estimated the average cost of general
overhead inputs by allocating them to CM according to
the proportion that CM service providers constitute of
 
Figure 2 Variation in unit cost: Cost per patient-quarter of CM services provided. Data from October 2008 through September, 2009; (n =
14 I-TECH supported ART sites).
Figure 3 Variation in unit cost: Cost per successful exit from CM services. Data from October 2008 through September, 2009; (n = 14 I-
TECH supported ART sites).
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head functions. A second limitation is that the definition
of “successful exits” from the program was not operatio-
nalized consistently across the study sites, nor was it
linked to quantified improvements in adherence. How-
ever, the high correlations between service volumes and
“successful exits,” and between the unit costs of these
two outputs measures, suggest that despite variation
across sites in its precise operational definition, the
number of “successful exits” appears to be an outcome
predominantly determined by the extent of services.
Thus, varied definitions may still represent aspects of
the same underlying process.
Cost analyses have a variety of important management
and budget projection uses. However, since they do not
evaluate health outcomes, they do not provide the gui-
dance for program funding or resource allocation deci-
sions conferred by cost-effectiveness analyses. A definitive
analysis of the cost-effectiveness of improving adherence
would entail a comparative assessment of an array of effec-
tive measures to improve adherence. These include elimi-
nating ART co-payments (in settings that have them),
payments for drugs to treat opportunistic infections,
improved personnel training, and providing meals and
reimbursing for transportation for participants [11]. They
might also include use of electronic devices for medication
use monitoring, other economic incentives, and cell
phone-based supervision [15]. A recent review of interven-
tions to increase adherence to ART in sub-Saharan Africa
found that some methods appear to have benefit but that
these benefits may be limited and temporary, or be con-
fined to specific settings or the precise intervention con-
tent. In addition many of the results depended on
observational studies rather than controlled trials [16].
Thus, completion of a technically sophisticated analysis
may be years away. Pending funding for randomized,
multi-arm trials that document the costs and benefits of a
range of adherence promotion strategies, a first step would
be a cost-effectiveness analysis of a CM program versus a
standard ART program without any adherence interven-
tion. Lacking strong evidence on which candidate methods
are likely to be most cost-effective, program managers
should also be encouraged to try methods they deem
appropriate for their respective settings, and to document
the costs and resulting changes in adherence or health
status.
Absent a cost-effectiveness assessment, it is nevertheless
useful to place our unit cost estimates in context. ART has
recently been estimated to cost $643 per patient-year in
Ethiopia [17]. Discounting at 3% per annum, and assuming
12 ART-years, the lifetime cost of ART is $6,400. The CM
program thus adds 0.52% ($33/$6,400) to the lifetime cost
of treatment for those patients receiving CM. Let us
assume, perhaps pessimistically, that the CM program has
no effect on 90% of those classified as having had a “suc-
cessful exit” and that the remaining 10% are returned to
normal adherence. The $840 ($84/10%) per CM client
restored to normal adherence would thus add 13.1% to
the lifetime cost of ART ($840/$6,400) per successful exit;
or the equivalent of an additional 16 months of ART
($840/$643) for the patients receiving CM. This rough cal-
culation does not account for changes in treatment costs
resulting from greater adherence, or for the potential
reduction in transmission to partners including the trans-
mission of drug-resistant strains of HIV.
The evaluation of incremental cost-effectiveness may
not form a sufficient basis for deciding whether to invest
in CM services. Once patients have been accepted for
treatment, there is an ethical obligation to make reason-
able efforts to ensure that they benefit from those ser-
vices. Yet, this perspective begs the question of what
constitutes a “reasonable” additional effort, especially in
resource-constrained countries such as Ethiopia. Pro-
gram managers will not invest unlimited resources in a
small number of poorly adhering patients, at the expense
of expanded access to ART or less intensive but success-
ful CM efforts. Ultimately, what is deemed “reasonable”
depends on a wide range of factors that may be best
decided by local program managers. Nevertheless, this
decision should be informed by an understanding of the
cost-effectiveness of additional investments in CM.
Finally, the variation in unit costs reported here suggest
that there may be opportunities to identify staffing pat-
terns that increase overall program efficiency, thus free-
ing increasingly constrained HIV resources with no
additional investment.
Conclusion
Case management for ART patients in Ethiopia who are
at risk for poor adherence costs an average of $33 per
patient served, or $84 per patient who successfully exits
the program. The data reported in this study reflect
wide variation in unit costs among the study sites and
suggest that high patient volume may be a major deter-
minant of CM program efficiency. The observed varia-
tions in unit costs also indicate that there may be
opportunities to identify staffing patterns that increase
overall program efficiency.
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